Literature DB >> 24661834

B-type natriuretic peptide predicts stroke of presumable cardioembolic origin in addition to coronary artery calcification.

K Kara1, J Gronewold, T Neumann, A A Mahabadi, C Weimar, N Lehmann, K Berger, H I M Kälsch, M Bauer, M Broecker-Preuss, S Möhlenkamp, S Moebus, K-H Jöckel, R Erbel, D M Hermann.   

Abstract

BACKGROUND AND
PURPOSE: B-type natriuretric peptide (BNP) is a marker of cardiac dysfunction that is released from myocytes in response to ventricular wall stress. Previous studies suggested that BNP predicts stroke events in addition to classical risk factors. It was suggested that the BNP-associated risk results from coronary atherosclerosis or atrial fibrillation.
METHODS: Three thousand six hundred and seventy five subjects from the population-based Heinz Nixdorf Recall study (45-75 years; 47.6% men) without previous stroke, coronary heart disease, myocardial infarcts, open cardiac valve surgery, pacemakers and defibrillators were followed up over 110.1 ± 23.1 months. Cox proportional hazards regressions were used to examine BNP as a stroke predictor in addition to vascular risk factors (age, gender, systolic blood pressure, low-density lipoprotein, high-density lipoprotein, diabetes, smoking), renal insufficiency, atrial fibrillation/known heart failure and coronary artery calcification.
RESULTS: Eighty-nine incident strokes occurred (80 ischaemic, 9 hemorrhagic). Subjects suffering stroke had significantly higher BNP values at baseline than the remaining subjects [26.3 (Q1; Q3 = 12.9; 51.0) vs. 17.4 (9.4; 31.4); P < 0.001]. In a multivariable regression, log10 BNP was an independent stroke predictor [hazard ratio 1.96, 95% confidence interval (CI) 1.13-3.41; P = 0.017] in addition to age (1.24 per 5 years, CI 1.04-1.49; P = 0.016), systolic blood pressure (1.25 per 10 mmHg, CI 1.14-1.38; P < 0.001), smoking (2.05, CI 1.24-3.39; P = 0.005), atrial fibrillation/heart failure (2.25, CI 1.05-4.83; P = 0.037) and computed-tomography-based log10 (coronary artery calcification + 1) (1.47, CI 1.15-1.88; P = 0.002). Log10 BNP predicted stroke in men but not women, both in subjects ≤65 and >65 years. In subsequent analyses, BNP discriminated the incidence of cardioembolic stroke (P for trend = 0.001), but not stroke of macroangiopathic (P = 0.555), microangiopathic (P = 0.809) or unknown (P = 0.367) origin.
CONCLUSIONS: BNP predicts presumable cardioembolic stroke independent of coronary calcification.
© 2014 The Author(s) European Journal of Neurology © 2014 EAN.

Entities:  

Keywords:  brain natriuretic peptide; coronary calcium; risk prediction

Mesh:

Substances:

Year:  2014        PMID: 24661834     DOI: 10.1111/ene.12411

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  4 in total

1.  Indexes of subclinical atherosclerosis: signposts on the highway to disease.

Authors:  Sudha Seshadri
Journal:  JACC Cardiovasc Imaging       Date:  2014-11-10

Review 2.  Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest.

Authors:  Dorin Harpaz; Evgeni Eltzov; Raymond C S Seet; Robert S Marks; Alfred I Y Tok
Journal:  Biosensors (Basel)       Date:  2017-08-03

3.  NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: The getABI-study.

Authors:  Henrik Rudolf; Andreas Mügge; Hans J Trampisch; Hubert Scharnagl; W März; Kaffer Kara
Journal:  Int J Cardiol Heart Vasc       Date:  2020-06-05

Review 4.  B-Type Natriuretic Peptide as a Significant Brain Biomarker for Stroke Triaging Using a Bedside Point-of-Care Monitoring Biosensor.

Authors:  Dorin Harpaz; Raymond C S Seet; Robert S Marks; Alfred I Y Tok
Journal:  Biosensors (Basel)       Date:  2020-08-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.